Bristol Myers Squibb Foundation: Robert A. Winn Diversity in Clinical Trials Award Program
Deadline: May 13, 2024
Category: Career Development,
The Robert A. Winn Diversity in Clinical Trials Award Program was created to increase diversity in clinical trials and transform the clinical research landscape.
The program invites applications for the Robert A. Winn Diversity in Clinical Trials: Career Development Award (Winn CDA) program, supported by the Bristol Myers Squibb Foundation. The two-year program is designed to support the career development of early-stage investigator (as defined by NIH) physicians from diverse backgrounds, and physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Clinical research areas include cancer, cardiovascular disease, and immunologic disorders.
The Winn CDA provides $120,000 annually for two years to institutions sponsoring scholars. Funding is expected to cover a percentage of each scholar’s salary, equivalent to 40 percent of their time. Scholars are required to receive mentorship from a seasoned clinical investigator at a clinical trial site or institution and are expected to actively participate in their mentor’s clinical trial, which must meet the FDA Clinical Trial Definition.
While physicians from groups underrepresented in medicine (URiM) are highly encouraged to apply, applicants need not fall under the URiM population to participate in this program. To be eligible, candidates must hold the degree of MD, MD/PhD, DO, or DO/PhD and be U.S. citizens or Lawful Permanent Residents (LPRs) as defined by the U.S. Department of Homeland Security.